Medication adherence firm launches COVID-19 support offering

HealthBeacon, a medication adherence technology company, has launched a COVID-19 support offering for patients on injectable therapies.

The organisation has developed the Injection Care Management System for patients that self-administer injectable medication in their homes.

During this pandemic, it is critical that people with chronic conditions continue to take their medications as prescribed by their healthcare professionals, while maintaining social distancing and avoiding unnecessary exposures. For these reasons, the HealthBeacon Injection Care Management System is being expanded to offer additional services to further support individuals in their homes.   

The offering, which is now available to laya healthcare’s 600,000 members, includes: virtual care support, co-ordination of medication delivery, medical waste collection, and home monitoring with the HealthBeacon Smart Sharps Bin. This service will aim to reduce the number of visits to the pharmacy and hospitals for those ‘at-risk’, while ensuring patients will continue to take critical medications.

Jim Joyce, CEO HealthBeacon, said: “We are delighted that laya healthcare has agreed to cover this service for their members during these unprecedented times. It is critical to adapt and innovate to ensure continued support to patients. Digital health technology has a huge role to play during COVID-19 and we want to ensure vulnerable patients are able to access critical medications.” 

John McCall, director of claims and provider relations at laya healthcare welcomed the support provided by HealthBeacon to its members, adding: “Members who need to regularly inject themselves at home will welcome this new service we’re now offering as part of our enhanced healthcare benefits, available at no additional cost until the end of June 2020. It’s just another way we’re looking after our members, always.”